PharmaCompass PK/PD Modeling - Coming Soon
PharmaCompass PK/PD — Coming Soon!
PharmaCompass PK/PD is an advanced antimicrobial dosing optimization application currently in development by Gregory K. Perry, PharmD, BCPS, BCIDP — a board-certified infectious diseases pharmacist with over 30 years of clinical experience in critical care and antimicrobial stewardship.
What is PharmaCompass PK/PD?
PharmaCompass PK/PD is a Monte Carlo simulation-based clinical decision support tool designed to help practicing pharmacists optimize antimicrobial dosing in real time. Unlike traditional dosing calculators, PharmaCompass PK/PD uses probability-based modeling to predict the likelihood that a given dose will achieve the pharmacodynamic target needed to maximize bacterial kill while minimizing toxicity risk.
What It Will Do for the Practicing Pharmacist:
- Optimize antimicrobial exposures — calculate the probability of pharmacodynamic target attainment (PTA) for individual patients based on their unique renal function, weight, and pathogen MIC
- Support AUC-guided dosing — particularly for vancomycin and other narrow therapeutic index agents
- Monte Carlo simulation — run thousands of simulated patient scenarios to determine the optimal dose and interval for your patient population
- Organism-specific modeling — tailor dosing recommendations based on site of infection, organism, and local resistance patterns
- Stewardship integration — support de-escalation decisions, IV-to-oral transitions, and duration of therapy recommendations grounded in PK/PD principles
Who Is It For?
PharmaCompass PK/PD is built for clinical pharmacists, infectious diseases specialists, antimicrobial stewardship programs, and advanced practice providers who want to move beyond weight-based dosing and apply rigorous PK/PD science to every antimicrobial decision.
Coming Soon
PharmaCompass PK/PD is currently in quality assurance testing and will be available exclusively through PharmaCompass Education, LLC. Subscribers to PharmaCompass InPHARMation will be the first to know when it launches.
Stay tuned for updates at pharmacompasseducation.com